These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25224311)

  • 1. T-cell-replete haploidentical stem cell transplantation is highly efficacious for relapsed and refractory childhood acute leukaemia.
    Kobayashi S; Ito M; Sano H; Mochizuki K; Akaihata M; Waragai T; Ohara Y; Hosoya M; Ohto H; Kikuta A
    Transfus Med; 2014 Oct; 24(5):305-10. PubMed ID: 25224311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
    Mariotti J; Devillier R; Bramanti S; Sarina B; Furst S; Granata A; Faucher C; Harbi S; Morabito L; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):627-632. PubMed ID: 29197681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Arm Non-Blinded Multicenter Clinical Trial on T-Cell-Replete Haploidentical Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin for Relapsed and Refractory Pediatric Acute Leukemia.
    Kada A; Kikuta A; Saito AM; Kato K; Iguchi A; Yabe H; Ishida H; Hyakuna N; Takahashi Y; Nagasawa M; Hashii Y; Umeda K; Matsumoto K; Fujisaki H; Yano M; Nakazawa Y; Sano H
    Kurume Med J; 2021 Oct; 66(3):161-168. PubMed ID: 34421094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell replete haploidentical stem cell transplantation with low dose anti-thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors.
    Sano H; Mochizuki K; Kobayashi S; Ohara Y; Takahashi N; Kudo S; Ikeda K; Ohto H; Kikuta A
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1519. PubMed ID: 34291886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
    Yan CH; Liu QF; Wu DP; Zhang X; Xu LP; Zhang XH; Wang Y; Huang H; Bai H; Huang F; Ma X; Huang XJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1311-1319. PubMed ID: 28483716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia.
    Sano H; Mochizuki K; Kobayashi S; Ohara Y; Ito M; Waragai T; Takahashi N; Ikeda K; Ohto H; Kikuta A
    Int J Hematol; 2018 Jul; 108(1):76-84. PubMed ID: 29508228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents.
    Sano H; Mochizuki K; Kobayashi S; Ohara Y; Takahashi N; Kudo S; Waragai T; Ikeda K; Ohto H; Kikuta A
    Front Pediatr; 2021; 9():743294. PubMed ID: 34722423
    [No Abstract]   [Full Text] [Related]  

  • 8. Chimeric antigens receptor T cell therapy as a bridge to haematopoietic stem cell transplantation for refractory/ relapsed B-cell acute lymphomalastic leukemia.
    Zhang Y; Chen H; Song Y; Tan X; Zhao Y; Liu X; Li Z; Yang F; Jiang M; Gao Z; Wu T
    Br J Haematol; 2020 Apr; 189(1):146-152. PubMed ID: 31869864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.
    Lang P; Teltschik HM; Feuchtinger T; Müller I; Pfeiffer M; Schumm M; Ebinger M; Schwarze CP; Gruhn B; Schrauder A; Albert MH; Greil J; Urban C; Handgretinger R
    Br J Haematol; 2014 Jun; 165(5):688-98. PubMed ID: 24588540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
    Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The outcomes of the thirty patients with refractory leukemia treated with related HLA haploidentical stem cells transplantation].
    Wu BY; Guo KY; Song CY; Wu LX; Yang YL; Li YH; Xiao LL
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):130-2. PubMed ID: 16624123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord Haploidentical Non-In Vitro T Cell Depletion Allogeneic Hematopoietic Stem Cell Transplantation Reduces Relapse of Refractory Acute Leukemia.
    Wang J; Wang Z; Wei W; Zhang W; Zhang T; Cheng H; Fei X; Yin Y; Gu J; Yuan L
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):121-128. PubMed ID: 30205230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
    Duléry R; Bastos J; Paviglianiti A; Malard F; Brissot E; Battipaglia G; Médiavilla C; Giannotti F; Banet A; de Wyngaert ZV; Ledraa T; Belhocine R; Sestili S; Adaeva R; Lapusan S; Isnard F; Legrand O; Vekhoff A; Rubio MT; Ruggeri A; Mohty M
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1407-1415. PubMed ID: 30871978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.
    Zeidan AM; Forde PM; Symons H; Chen A; Smith BD; Pratz K; Carraway H; Gladstone DE; Fuchs EJ; Luznik L; Jones RJ; Bolaños-Meade J
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):314-8. PubMed ID: 24296490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.
    Locatelli F; Merli P; Pagliara D; Li Pira G; Falco M; Pende D; Rondelli R; Lucarelli B; Brescia LP; Masetti R; Milano GM; Bertaina V; Algeri M; Pinto RM; Strocchio L; Meazza R; Grapulin L; Handgretinger R; Moretta A; Bertaina A; Moretta L
    Blood; 2017 Aug; 130(5):677-685. PubMed ID: 28588018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
    Pagliardini T; Castagna L; Harbi S; Porta MD; Rey J; Fürst S; Bramanti S; Saillard C; Legrand F; Maisano V; Faucher C; Granata A; Hospital MA; Lining W; Weiller PJ; Calmels B; Charbonnier A; Lemarie C; Chabannon C; Vey N; Mokart D; Blaise D; Devillier R
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1803-1809. PubMed ID: 31128325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.
    Gao XN; Lin J; Wang SH; Huang WR; Li F; Li HH; Chen J; Wang LJ; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2019 Jan; 98(1):185-193. PubMed ID: 30143831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.
    Nachbaur D; Eibl B; Kropshofer G; Meister B; Mitterschiffthaler A; Schennach H; Fischer G; Kopp M; Gunsilius E; Gastl G
    J Hematother Stem Cell Res; 2002 Aug; 11(4):731-7. PubMed ID: 12201962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.